S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
S&P 500   3,629.65 (-0.16%)
DOW   29,872.47 (-0.58%)
Log in

Satsuma Pharmaceuticals Earnings Date, Estimates & History

+0.07 (+1.57 %)
(As of 11/25/2020 12:00 AM ET)
Today's Range
Now: $4.54
50-Day Range
MA: $4.03
52-Week Range
Now: $4.54
Volume194,451 shs
Average Volume739,223 shs
Market Capitalization$79.10 million
P/E RatioN/A
Dividend YieldN/A


Satsuma Pharmaceuticals (NASDAQ:STSA) Earnings Information

Satsuma Pharmaceuticals last issued its earnings data on November 10th, 2020. The financial services provider reported ($0.69) EPS for the quarter, meeting the consensus estimate of ($0.69). Satsuma Pharmaceuticals has generated ($4.80) earnings per share over the last year. Satsuma Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 9th, 2021 based off prior year's report dates.

Satsuma Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Satsuma Pharmaceuticals (NASDAQ:STSA) Earnings Estimates

2020 EPS Consensus Estimate: ($2.90)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.68)($0.68)($0.68)
Q2 20201($0.72)($0.72)($0.72)
Q3 20201($0.74)($0.74)($0.74)
Q4 20201($0.76)($0.76)($0.76)

Satsuma Pharmaceuticals (NASDAQ STSA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/12/2020Q2 2020($0.72)($0.65)($0.65)N/A
5/12/2020Q1 2020($0.67)($0.6758)($0.68)N/A
1/30/2014Q4 2013$0.35$0.35$0.35$115.64 million$113.51 millionN/A
10/24/2013Q3 2013$0.40$0.33$0.33$83.73 million$114.44 millionN/A
7/25/2013Q2 2013$0.36$0.44$0.44$79.06 million$122.42 millionListen
4/24/2013Q1 2013$0.35$0.36$0.36$78.50 million$114.46 millionN/A
1/24/2013Q4 2012$0.53$0.52$0.71N/A
10/25/2012Q3 2012$0.49$0.49$0.49N/A
7/26/2012Q2 2012$0.37$0.51($4.11)N/A
4/25/2012Q1 2012$0.28$0.30$0.39N/A
1/25/2012Q4 2011$0.23$0.24$0.24N/A
10/25/2011Q3 2011$0.11$0.18$0.18N/A
7/27/2011Q2 2011$0.06$0.12$0.12N/A
4/19/2011Q1 2011($0.29)$0.09$0.09N/A
1/25/2011Q4 2010($0.68)($0.76)$11.27N/A
10/19/2010Q3 2010($3.95)$1.32$1.32N/A
7/27/2010Q2 2010($66.45)($73.68)($73.68)N/A
4/27/2010Q1 2010($131.58)($112.37)($112.37)N/A
2/1/2010Q4 2009($28.95)($421.84)($421.84)N/A
10/22/2009Q3 2009($42.76)($299.21)($10.85)N/A
7/23/2009Q2 2009($41.45)($42.96)($42.96)N/A
4/23/2009Q1 2009($42.76)($31.45)($31.45)N/A
1/27/2009Q4 2008($167.76)($167.57)$115.32N/A
10/21/2008Q3 2008$13.16$6.32$6.32N/A
7/22/2008Q2 2008$7.89$14.80$14.80N/A
4/21/2008Q1 2008$13.16$3.68$3.68N/A
1/28/2008Q4 2007$21.71$21.45$21.45N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.